Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro.
about
Novel immunotherapeutic approaches to the treatment of urothelial carcinomaApplications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapyEvolving immunotherapy strategies in urothelial cancerIntravesical therapy for urothelial carcinoma of the urinary bladder: a critical review.Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guérin and prospective use in immunotherapy of bladder cancer.Antitumor effects of human interferon-alpha 2b secreted by recombinant bacillus Calmette-Guérin vaccine on bladder cancer cells.Bladder Cancer Immunotherapy: BCG and Beyond.Nonmuscle invasive bladder cancer: a primer on immunotherapy.Immunotherapy for urothelial carcinoma: current status and perspectives.MUC1-based recombinant Bacillus Calmette-Guerin vaccines as candidates for breast cancer immunotherapy.Mycobacterium bovis bacillus Calmette-Guérin-induced macrophage cytotoxicity against bladder cancer cells.From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa.The mechanism of action of BCG therapy for bladder cancer--a current perspective.Recombinant bacillus Calmette-Guérin in urothelial bladder cancer immunotherapy: current strategies.Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer.Inflammation and Cancer: What Can We Therapeutically Expect from Checkpoint Inhibitors?Future directions in bladder cancer immunotherapy: towards adaptive immunity.The mannose-sensitive hemagglutination pilus strain of Pseudomonas aeruginosa shift peritoneal milky spot macrophages towards an M1 phenotype to dampen peritoneal dissemination.Interleukin-10 inhibits Mycobacterium bovis bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against bladder cancer cells.Construction of a recombinant-BCG containing the LMP2A and BZLF1 genes and its significance in the Epstein-Barr virus positive gastric carcinoma.
P2860
Q26744347-D41F11A7-88EC-41D4-8D56-FCEB3B707CD0Q26798372-99915FE3-F525-4133-AF3D-1389331120BAQ26823557-B4F566B8-3303-4D89-835D-620B4759C59BQ34751946-1153FDC6-004D-4DD6-BC7D-E45897FB0D41Q35215350-1D5FFF66-65A9-4AC3-B694-7CAFD01790F8Q35946382-6C22A164-64AE-4C43-A62C-8FCA2F5EA046Q36072179-7A73525A-04B5-4CE4-AE6E-B9F3621CFE21Q37094072-4251A2D9-77DC-49B6-8925-AD581CCD5F70Q37137381-A10B62B4-97D0-46E7-B057-3C7629E22103Q37737313-5422D6A1-24D3-4EDC-B85A-920859E74894Q37791443-413F987B-429E-4123-AC31-8B4F22D63215Q38142595-BEAC134A-A9BE-4AFB-BEDC-9C2A40B7C842Q38184849-0639B15A-1793-4678-9C43-E108B0BBF239Q38251141-A5C8DEAC-AAA7-486C-A061-43CBB2248D1DQ38385719-941F283F-4649-409B-9539-BE7B430876AAQ38542639-2C32E183-D072-42E7-BEB8-49E82224116AQ38727522-530F1BBC-41D1-4712-BDB9-09106E2466E6Q39037779-C1C0FC67-40DA-47EB-B7CB-190BCC81F162Q39740932-AE1E0A1C-85B8-4A36-8B8F-DEA64875BF44Q42226962-A023D328-5C59-470D-9780-4554D9340D95
P2860
Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Recombinant bacillus Calmette- ...... er cancer cell lines in vitro.
@en
Recombinant bacillus Calmette-Guérin
@nl
type
label
Recombinant bacillus Calmette- ...... er cancer cell lines in vitro.
@en
Recombinant bacillus Calmette-Guérin
@nl
prefLabel
Recombinant bacillus Calmette- ...... er cancer cell lines in vitro.
@en
Recombinant bacillus Calmette-Guérin
@nl
P2093
P1476
Recombinant bacillus Calmette- ...... er cancer cell lines in vitro.
@en
P2093
Michael A O'Donnell
Wujiang Liu
Xiaohong Chen
P2860
P2888
P304
P356
10.1007/S00262-009-0673-Z
P577
2009-02-13T00:00:00Z
P6179
1007091254